BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12814451)

  • 1. A novel metabolic pathway of morphine: formation of morphine glucosides in cancer patients.
    Chen XY; Zhao LM; Zhong DF
    Br J Clin Pharmacol; 2003 Jun; 55(6):570-8. PubMed ID: 12814451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of phase II drug metabolites in equine urine by micellar electrokinetic capillary chromatography.
    Taylor MR; Westwood SA; Perrett D
    J Chromatogr A; 1996 Sep; 745(1-2):155-63. PubMed ID: 8843684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural evaluation of the glucuronides of morphine and formoterol using chemical derivatization with 1,2-dimethylimidazole-4-sulfonyl chloride and liquid chromatography/ion trap mass spectrometry.
    Salomonsson ML; Bondesson U; Hedeland M
    Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2685-97. PubMed ID: 18677706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct determination of codeine, norcodeine, morphine and normorphine with their corresponding O-glucuronide conjugates by high-performance liquid chromatography with electrochemical detection.
    Verwey-van Wissen CP; Koopman-Kimenai PM; Vree TB
    J Chromatogr; 1991 Oct; 570(2):309-20. PubMed ID: 1797846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of morphine glucuronides in cancer pain.
    Mercadante S
    Palliat Med; 1999 Mar; 13(2):95-104. PubMed ID: 10474692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes.
    Andersson M; Stephanson N; Ohman I; Terzuoli T; Lindh JD; Beck O
    Drug Test Anal; 2014 Apr; 6(4):317-24. PubMed ID: 23720205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
    Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
    J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans.
    Yeh SY; Gorodetzky CW; Krebs HA
    J Pharm Sci; 1977 Sep; 66(9):1288-93. PubMed ID: 903867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-beta-D-glucuronide, morphine-6-beta-D-glucuronide, and codeine-6-beta-D-glucuronide in human urine.
    Murphy CM; Huestis MA
    J Mass Spectrom; 2005 Nov; 40(11):1412-6. PubMed ID: 16258895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary electrophoresis-mass spectrometry determination of morphine and its isobaric glucuronide metabolites.
    Isbell TA; Strickland EC; Hitchcock J; McIntire G; Colyer CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 980():65-71. PubMed ID: 25589256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine in serum.
    Sartori D; Lewis T; Breaud A; Clarke W
    Clin Biochem; 2015 Dec; 48(18):1283-90. PubMed ID: 26118474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatography-mass spectrometry-mass spectrometry analysis of morphine and morphine metabolites and its application to a pharmacokinetic study in male Sprague-Dawley rats.
    Zheng M; McErlane KM; Ong MC
    J Pharm Biomed Anal; 1998 Feb; 16(6):971-80. PubMed ID: 9547700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Acetylmorphine detected in the absence of morphine in pain management patients.
    Crews B; Mikel C; Latyshev S; West R; West C; Pesce A; Friel P
    Ther Drug Monit; 2009 Dec; 31(6):749-52. PubMed ID: 19745789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
    Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
    Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans.
    Aasmundstad TA; Størset P
    Hum Exp Toxicol; 1998 Jun; 17(6):347-52. PubMed ID: 9688360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of morphine and its metabolites in morphine-dependent subjects.
    Yeh SY
    J Pharmacol Exp Ther; 1975 Jan; 192(1):201-10. PubMed ID: 235634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay for codeine, morphine and ten potential urinary metabolites by gas chromatography--mass fragmentography.
    Cone EJ; Darwin WD; Buchwald WF
    J Chromatogr; 1983 Jul; 275(2):307-18. PubMed ID: 6619237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain.
    Andersen G; Sjøgren P; Hansen SH; Jensen NH; Christrup L
    Eur J Pain; 2004 Jun; 8(3):263-71. PubMed ID: 15109977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct pharmacological properties of morphine metabolites at G(i)-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor.
    Frölich N; Dees C; Paetz C; Ren X; Lohse MJ; Nikolaev VO; Zenk MH
    Biochem Pharmacol; 2011 May; 81(10):1248-54. PubMed ID: 21396918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved detection of opioid use in chronic pain patients through monitoring of opioid glucuronides in urine.
    Dickerson JA; Laha TJ; Pagano MB; O'Donnell BR; Hoofnagle AN
    J Anal Toxicol; 2012 Oct; 36(8):541-7. PubMed ID: 22833646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.